Tag: Lord Turnberg

The below Parliamentary question was asked by Lord Turnberg on 2015-11-10.

To ask Her Majesty’s Government what efforts they have made to allow endangered refugees in Camp Liberty to come to the UK.

Baroness Anelay of St Johns

In 2011 the Government of Iraq signed a Memorandum of Understanding with the UN Assistance Mission to Iraq which allowed the UN High Commissioner for Refugees (UNHCR) to make assessments on applications made by the residents for relocation. The UNHCR assessment process is underway, and a number of residents have now been relocated to third countries.

The UK has re-admitted four individuals from Camp Ashraf who hold valid UK travel documents. The Home Office exceptionally agreed to consider whether 52 residents of Camp Liberty previously settled in the UK, but who left many years ago, should be readmitted. Seventeen residents approved for resettlement in the UK by the Home Office are now in the UK. The UNHCR has also referred 35 further residents and a decision from the Home Office is pending.

The below Parliamentary question was asked by Lord Turnberg on 2016-07-08.

To ask Her Majesty’s Government, following the removal of the role of the National Clinical Director for gastrointestinal and liver diseases, what other forms of information and advice on those diseases are available to NHS England.

Lord Prior of Brampton

In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.

Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.

NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.

Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.

The below Parliamentary question was asked by Lord Turnberg on 2015-11-23.

To ask Her Majesty’s Government what proportion of the UK’s GDP was spent on social care in each year between 1999 and 2015.

Lord Prior of Brampton

Expenditure on adult social care in England as a proportion of gross domestic product (GDP) is detailed in the table below. Expenditure data for the rest of the United Kingdom is not available.

Financial Year	UK GDP (£ billions)	England adult social care (£ billions)	Proportion of UK GDP on England’s adult social care
1999-2000	980	8.50	0.87%
2000-01	1,040	9.05	0.87%
2001-02	1,080	9.48	0.88%
2002-03	1,140	10.30	0.90%
2003-04	1,210	11.51	0.95%
2004-05	1,270	12.62	0.99%
2005-06	1,350	13.46	1.00%
2006-07	1,430	13.98	0.98%
2007-08	1,500	14.33	0.96%
2008-09	1,500	15.08	1.01%
2009-10	1,500	15.72	1.05%
2010-11	1,570	16.06	1.02%
2011-12	1,630	15.55	0.95%
2012-13	1,680	15.35	0.91%
2013-14	1,760	15.51	0.88%
2014-15	1,830	15.51	0.85%

2014-15 is the last year we have outturn data for spend on adult social care.

The cash terms figures and comparisons to GDP for gross spend on children and young people’s services in England, calculated from the Department for Education section 251 data returns are set out in the table below. Expenditure data for the rest of the UK is not available.

Financial Year	UK GDP (£ billions)	England children’s social care (£ billions)	Proportion of UK GDP on England’s children’s social care
2010-11	1,570	9.26	0.59%
2011-12	1,630	8.65	0.53%
2012-13	1,680	8.88	0.53%
2013-14	1,760	8.99	0.51%

2010-11 was the first time that national level income and expenditure data were presented in the form of a statistical release. To derive comparable figures for previous years would incur disproportionate cost.

The below Parliamentary question was asked by Lord Turnberg on 2016-07-08.

To ask Her Majesty’s Government whether NHS England will seek advice from specialist gastrointestinal disease societies following the removal of the role of National Clinical Director for that area.

Lord Prior of Brampton

In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.

Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.

NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.

Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.

The below Parliamentary question was asked by Lord Turnberg on 2015-11-23.

To ask Her Majesty’s Government how many UK citizens there were over the age of 75 in each of the years between 1999 and 2015.

Lord Bridges of Headley

The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

The below Parliamentary question was asked by Lord Turnberg on 2016-07-08.

To ask Her Majesty’s Government what mechanisms they plan to employ to seek advice on workforce planning for gastroenterology following the removal of the role of National Clinical Director for that area.

Lord Prior of Brampton

In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.

Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.

NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.

Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.

The below Parliamentary question was asked by Lord Turnberg on 2015-11-23.

To ask Her Majesty’s Government when they expect NICE to publish its opinion about the availability of Translarna for the treatment of patients with Duchene Muscular Dystrophy, following its approval by the European Medicines Agency in July 2014.

Lord Prior of Brampton

The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the clinical and cost effectiveness of drugs and treatments. NICE is currently evaluating Translarna (ataluren) for the treatment of Duchenne muscular dystrophy through its highly specialised technology programme. NICE currently expects to publish its final guidance in February 2016.

The NHS in England is legally required to fund drugs and treatments recommended in NICE highly specialised technology guidance within three months of its final guidance being issued. In the absence of guidance from NICE, it is for commissioners to make decisions on whether to fund medicines based on an assessment of the available evidence.

The below Parliamentary question was asked by Lord Turnberg on 2016-07-20.

To ask Her Majesty’s Government, further to the Written Answer by Baroness Verma on 7 July 2016 (HL799), what discussion they have had with the Palestinian Authority about its non-attendance at meetings with Israeli officials on the Joint Water Committee.

Baroness Anelay of St Johns

Continuity of water supply to the West Bank is essential for both the basic needs of Palestinians and for stability and security more widely. The UK regularly raises the issue of water in the Occupied Palestinian Territories with the Palestinian Authority and Government of Israel. We encourage both parties to find a swift resolution to this issue and to reconvene the Joint Water Committee.

The below Parliamentary question was asked by Lord Turnberg on 2016-02-03.

To ask Her Majesty’s Government what proportion of EU immigrants were in receipt of benefit payments during the last two years for which figures are available.

Lord Freud

The information on benefit receipt by nationality is not available.

The Department has published statistics on working age benefit recipients claiming within 6 months of National Insurance Number (NINO) registration. This information is known as “Nationality at point of National Insurance number registration of DWP benefit claimants” and is included in the “Statistical Bulletin on National Insurance Number Allocations to Adult Overseas Nationals”.

The Government is looking at ways to reform the current administrative system under Universal Credit so that it will systematically record nationality and immigration status of migrants who make a claim.

The below Parliamentary question was asked by Lord Turnberg on 2016-02-03.

To ask Her Majesty’s Government what was the cost of benefit payments to EU immigrants during the last two years for which data are available.

Lord Freud

The information on benefit receipt by nationality is not available.

The Department has published statistics on working age benefit recipients claiming within 6 months of National Insurance Number (NINO) registration. This information is known as “Nationality at point of National Insurance number registration of DWP benefit claimants” and is included in the “Statistical Bulletin on National Insurance Number Allocations to Adult Overseas Nationals”.

The Government is looking at ways to reform the current administrative system under Universal Credit so that it will systematically record nationality and immigration status of migrants who make a claim.